IMMUNITYBIO

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IMMUNITYBIO was filed as Word mark on 03/01/2023 at the World Intellectual Property Organization.

Trademark Details Last update: July 18, 2023

Trademark form Word mark
File reference 1739959
Countries Australia Canada China European Community United Kingdom India Japan South Korea Mexico
Base trademark US No. , December 3, 2024
Application date March 1, 2023
Expiration date March 1, 2033

Trademark owner

9920 Jefferson Blvd.
Culver City CA 92032
US

Trademark representatives

3993 Howard Hughes Parkway, Suite 600 US

goods and services

05 Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope-based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents
42 Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases
44 Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations

Trademark history

Date Document number Area Entry
March 1, 2023 2023/26 Gaz US Registration

ID: 141739959